An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma
Julien Péron
(1)
,
Pascal Roy
(1, 2, 3)
,
T. Conroy
,
Françoise Desseigne
,
M. Ychou
(4)
,
S. Gourgou-Bourgade
,
T. Stanbury
,
L. Roche
(5)
,
B. Ozenne
(1)
,
M. Buyse
Pascal Roy
- Function : Author
- PersonId : 748360
- IdHAL : pascal-roy
- ORCID : 0000-0003-3837-3198
- IdRef : 094596441
T. Conroy
- Function : Author
Françoise Desseigne
- Function : Author
S. Gourgou-Bourgade
- Function : Author
T. Stanbury
- Function : Author
M. Buyse
- Function : Author